Delivery Order SPE2DB25D3404-SPE2DB25FUPTN
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,257.38 for DEPO-MEDROL 80 MG/ML vials on August 1, 2025, with completion expected by August 4, 2025. This firm fixed price, non-set-aside contract represents a pediatric or pharmaceutical supply order fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,404.04 to AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation, for the supply of Depo-Medrol 80 mg/mL vials. This delivery order contract was issued under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of DEPO-MEDROL 40 MG/ML vials, a specialty brand name medication, with a ceiling value of $4,234.53 and a period of performance through March 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary vehicle for the company...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $1,265.88 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, for the supply of Solu-Medrol 500 mg vials. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Solu-Medrol 40 mg vials valued at $5,223.67 with a firm fixed price structure. The contract, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of SOLU-MEDROL 2,000 mg vials. This non-set-aside, firm fixed-price delivery order has a ceiling value of $1,002.48 and an ultimate completion date of July 14, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for SOLU-MEDROL 1 gram vials valued at $3,330.42. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,281.64 on July 24, 2025, for the supply of Solu-Medrol 1 gram vials under a firm fixed price contract. This non-competitive delivery order, with an ultimate completion date of July 25, 2025, was funded by the Medical Supply Chain, the pharmaceutical procurement arm of the Defense Logistics Agency. The award represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Solu-Medrol 1 gram vials, with a ceiling value of $3,636.56. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SOLU-MEDROL 40 MG VIALS. The contract has a potential value of $2,269.95 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and does not have any major subcontractors listed. This award is part of a larger indefinite delivery...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPTNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,405.76 to AmerisourceBergen Drug Corp for DEPO-MEDROL 40 mg/ml vials on August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order for the federal government's military and healthcare supply chain needs. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's SPE2DX indefinite delivery contract functions as a global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This specific delivery order for DEPO-MEDROL represents one of numerous small-value transactions the company fulfills under this comprehensive contract vehicle, supporting Defense Health Agency requirements and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/12/25 |